UPDATE | January 16, 2026
Building an agile CDMO operations model through standardisation, simplification and scalability
Agility at Samsung Biologics is not a concept. It is how our plants run, how teams make decisions, and how projects stay on track.
As processes scale and modalities diversify, speed alone is not enough. What matters is the ability to respond quickly without creating new risk.
Jaeyun Kim, Senior Director of Drug Substance Manufacturing, shares how Samsung Biologics translates agility into repeatable execution through the ExellenS™ framework.
At the core are three principles that shape how we operate every day:
- Standardization that aligns processes, data, and decision-making across sites
- Simplification that removes friction from workflows before it slows a project down
- Scalability that allows facilities and processes to grow with the product, not against it
Together, these principles enable faster issue resolution, stronger execution, stable batch performance, and on-time delivery even as complexity increases.
Read the full article in Pharmaceutical Manufacturing & Packing Sourcer to see how this approach works in practice, not just on paper. (Pages 61 - 63)
Agility at Samsung Biologics is not a concept. It is how our plants run, how teams make decisions, and how projects stay on track.
As processes scale and modalities diversify, speed alone is not enough. What matters is the ability to respond quickly without creating new risk.
Jaeyun Kim, Senior Director of Drug Substance Manufacturing, shares how Samsung Biologics translates agility into repeatable execution through the ExellenS™ framework.
At the core are three principles that shape how we operate every day:
- Standardization that aligns processes, data, and decision-making across sites
- Simplification that removes friction from workflows before it slows a project down
- Scalability that allows facilities and processes to grow with the product, not against it
Together, these principles enable faster issue resolution, stronger execution, stable batch performance, and on-time delivery even as complexity increases.
Read the full article in Pharmaceutical Manufacturing & Packing Sourcer to see how this approach works in practice, not just on paper. (Pages 61 - 63)
Share article
Related Content